Factors Associated with the Length of First Time Hospitalization in a Referral Psychiatric Hospital in North of Iran
Author(s):
Abstract:
Background
Length of hospitalization is an important indicator for optimal management and to reduce and save the costs.Objective
Considering the limited hospital capacity as a referral center for psychiatric patients, the high prevalence of the disease, and the high expense of the treatment, this study aimed to identify the factors associated with psychiatric patients length of hospitalization.Methods
The data were obtained from the records of all patients hospitalized for the first time since the April 2007 to the March 2012. The data collection tool was a checklist comprising of demographic variables, variables related to the socioeconomic status, psychiatric disorders, and the related variables such as length of hospitalization and a previous history.Results
In the present study, 2397 (72.8% males and 27.2% females) medical documentations were investigated. Median length of stay was 25 days. Using the Cox model, the variables including age, educational level, material status, employment, the insurance status, the history of hospitalization at psychiatric center, type of treatment and disorder, duration of disorder, the referral source , and hospitalization during religious months (Ramadan and Muharram) and agricultural seasons had a significant relationship with the length of hospitalization (P value Keywords:
Language:
English
Published:
Iranian Journal of Psychiatry and Behavioral Sciences, Volume:11 Issue: 2, Jun 2017
Page:
19
https://www.magiran.com/p1735659
سامانه نویسندگان
مقالات دیگری از این نویسنده (گان)
-
Opium and Tobacco Use, and Outcome in COVID-19 Infected Patients: A Cross-Sectional Study
Amir Asadi, Forouzan Elyasi, Mahmood Moosazadeh, Iradj Maleki, Ideh Ghafour, Maryam Hassanian Badi, Hamidreza Namvar, Ehsan Dadgostar, Mahdi Salehi, *
International Journal of High Risk Behaviors and Addiction, Jun 2024 -
Antipsychotic Effects of Celecoxib Add-On Haloperidol in Schizophrenia: A Randomized Double-Blind Placebo-Controlled Clinical Trial
*, Nasrin Dodangi, Paria Azari,, Alireza Khalilian
Iranian Journal of Psychiatry and Behavioral Sciences, Mar 2024